4.7 Review

A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers

Related references

Note: Only part of the references are listed.
Article Surgery

Survival Predictors of Resectable Gallbladder Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database

Jisheng Zhu et al.

Summary: This study analyzed population-level data on resectable gallbladder carcinoma (GBC) according to the eighth edition of the American Joint Committee on Cancer staging system. The results showed that older age, increasing tumor size, adenocarcinoma, and advanced tumor/node stage were associated with a poorer prognosis after resection for GBC. Additionally, patients with resectable GBC can benefit from adjuvant therapy.

AMERICAN SURGEON (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Multimodal molecular imaging evaluation for early diagnosis and prognosis of cholangiocarcinoma

Jiong Liu et al.

Summary: Cholangiocarcinoma (CCA), an aggressive and deadly cancer, poses challenges in early diagnosis. Molecular imaging, a noninvasive diagnostic method that allows visualization of biological events at the cellular and molecular level, shows promise in CCA. This review discusses various molecular imaging techniques for CCA and explores the challenges and future directions in this field.

INSIGHTS INTO IMAGING (2022)

Article Oncology

Long non-coding RNA MEG3 regulates the progress of osteoarthritis by regulating the miR-34a/Klotho axis

Gaoxin Xiong et al.

Summary: By investigating the inhibition of long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) in osteoarthritis (OA), the study found that it can regulate the progression of OA by regulating the expression of FGF23, Bcl-2, Bax, TGF-β1, Caspase3, and Caspase8 through the miR-34a/Klotho axis.

ANNALS OF TRANSLATIONAL MEDICINE (2022)

Article Oncology

MEG3 Induces Cervical Carcinoma Cells' Apoptosis Through Endoplasmic Reticulum Stress by miR-7-5p/STC1 Axis

Xi Pan et al.

Summary: The study found that MEG3 was downregulated, miR-7-5p was upregulated, and overexpression of MEG3 or inhibition of miR-7-5p induced ERs-triggered apoptosis in CC cells. Furthermore, sh-STC1 could reverse the effects of MEG3 overexpression on CC cell apoptosis, and the dual luciferase reporter assay confirmed that miR-7-5p directly targeted MEG3 and STC1.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2021)

Article Medicine, General & Internal

LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421

Pei-Yin Chen et al.

Summary: The study revealed that long non-coding RNA MEG3 was downregulated in oral cancer, overexpression of MEG3 could inhibit the self-renewal and invasion abilities of oral CSCs, and miR-421 interacted directly with MEG3, with elevated levels of miR-421 reversing the inhibitory effects of MEG3 on oral CSCs.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)

Article Cell Biology

Long Non-coding RNA MEG3 Alleviated Ulcerative Colitis Through Upregulating miR-98-5p-Sponged IL-10

Yan Wang et al.

Summary: This study reveals the protective role of lncRNA MEG3 in the development of UC and may provide potential therapeutic targets for UC.

INFLAMMATION (2021)

Article Immunology

LncRNA-Meg3 promotes Nlrp3-mediated microglial inflammation by targeting miR-7a-5p

Jiao Meng et al.

Summary: This study demonstrates that Meg3 regulates microglia inflammation by targeting the miR-7a-5p/Nlrp3 pathway. The findings suggest that the inflammatory response induced by Meg3 may be achieved through the regulation of miR-7a-5p expression and Nlrp3 protein expression.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Cell Biology

LNCcation: lncRNA localization and function

Mary Catherine Bridges et al.

Summary: This review summarizes the current knowledge of subcellular localization of long noncoding RNAs (lncRNAs), factors controlling their localization, emerging themes, and discusses the implications of lncRNA localization on their function and cellular behavior, as well as opportunities for future research.

JOURNAL OF CELL BIOLOGY (2021)

Article Cell Biology

Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up-regulation by binding to microRNA-21

Liqiang Lin et al.

Summary: The study shows that MEG3 promotes autophagy and apoptosis in NPC cells by binding to miR-21, leading to enhanced PTEN expression. Overexpression of MEG3 in HK-1 cells can inhibit tumour formation.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Oncology

Long non-coding RNA MEG3 inhibits cell migration and invasion of non-small cell lung cancer cells by regulating the miR-21-5p/PTEN axis

Dongjin Lv et al.

Summary: Long non-coding RNAs (lncRNAs) are involved in various cancer types, including non-small cell lung cancer (NSCLC). The study found that MEG3 acts as a tumor suppressor by sponging miR-21-5p and increasing PTEN expression, thereby inhibiting migration and invasion of NSCLC cells. This suggests that MEG3 could be a potential therapeutic target for NSCLC treatment.

MOLECULAR MEDICINE REPORTS (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling

L. Gao et al.

Summary: Curcumin can inhibit the proliferation and induce apoptosis of gemcitabine-resistant non-small cell lung cancer by upregulating the expression of lncRNA-MEG3 and PTEN. This study provides evidence for the potential clinical application of curcumin in the treatment of gemcitabine-resistant non-small cell lung cancer.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Medicine, Research & Experimental

Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients

Wenjin Gao

Summary: Childhood acute lymphoblastic leukemia (cALL) is a common hematological malignancy with poor prognosis in children. This study found that the expression of long non-coding RNA maternally expressed gene 3 (lnc-MEG3) was decreased in cALL patients, but increased during induction therapy. High baseline and day 15 lnc-MEG3 expression were associated with prolonged event-free survival and overall survival in cALL patients.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)

Article Physiology

LncRNA MEG3 Protects Chondrocytes From IL-1β-Induced Inflammation via Regulating miR-9-5p/KLF4 Axis

Yijiang Huang et al.

Summary: The study demonstrates that MEG3 promotes chondrocyte proliferation and migration, while inhibiting apoptosis and inflammation by sponging miR-9-5p to induce KLF4 expression. This provides a potential therapy target for osteoarthritis treatment.

FRONTIERS IN PHYSIOLOGY (2021)

Article Biotechnology & Applied Microbiology

Mechanism of M2 macrophage-derived extracellular vesicles carrying lncRNA MEG3 in inflammatory responses in ulcerative colitis

Yu-Xuan Wang et al.

Summary: The study revealed that M2 macrophage-derived extracellular vesicles (M2-EVs) enhanced UC cell viability and reduced inflammatory responses by modulating the expression of MEG3 and the miR-20b-5p/CREB1 axis.

BIOENGINEERED (2021)

Article Oncology

A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis

Hong Pan et al.

Summary: PDAC is a highly devastating disease with poor prognosis and rising incidence worldwide. By analyzing the cellular composition of PDAC tumors, researchers found heterogeneity in cancer cells, dividing them into different subclusters with one cluster prominently contributed by metastatic PDAC cells, suggesting a critical role in tumor metastasis. Further analysis revealed potential therapeutic targets in these subclusters, providing a potential strategy for the treatment of cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

Original LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis

Shiliang Dong et al.

Summary: MEG3 and RBMS3 are low-expressed in breast cancer, negatively correlated with miR-141-3p, and positively correlated with each other. MEG3 inhibits BC cell proliferation and promotes apoptosis by down-regulating miR-141-3p and up-regulating RBMS3.

GENOMICS (2021)

Article Oncology

Wilms Tumor (Nephroblastoma), Version 2.2021

Frank Balis et al.

Summary: The NCCN Guidelines for Wilms Tumor focus on screening, diagnosis, staging, treatment, and management of Wilms tumor. Five-year survival is over 90%, with recommendations for multidisciplinary team management and consultation with pediatric oncologists to minimize toxicity and maximize cure.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Medicine, Research & Experimental

Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer

Qi-Rong Xu et al.

Summary: MEG3 inhibits FOXP3 expression and suppresses regulatory T cell differentiation and immune escape in EC mice by upregulating miR-149-3p via MDM2-mediated p53.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Oncology

Effects of LncRNA MEG3 on immunity and autophagy of non-small cell lung carcinoma through IDO signaling pathway

Chuanqiang Wang et al.

Summary: The study explored the effect of LncRNA MEG3 on the immunity and autophagy of non-small cell lung carcinoma through the IDO signaling pathway. Results showed that LncRNA MEG3 was low while miR-543 was high in peripheral blood and tissues of NSCLC patients, affecting their prognosis. LncRNA MEG3 regulates immunity and autophagy of NSCLC cells via the miR-543/IDO signaling pathway.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Cell Biology

LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway

Wei Li et al.

Summary: The study found that lncRNA BM466146.1 was downregulated in pancreatic cancer tissues and acted as a suppressor by regulating the expression of adjacent gene ZNF24. ZNFTR interacted with ATF3 to modulate ZNF24 expression, which in turn inhibited VEGFA transcription, reducing the proliferative, metastatic, and pro-angiogenic abilities of pancreatic cancer cells. This downregulation of ZNFTR in pancreatic cancer resulted in decreased ZNF24 expression and increased VEGFA expression, promoting the development of the disease.

CELL DEATH & DISEASE (2021)

Article Genetics & Heredity

Prognostic Value of MEG3 and Its Correlation With Immune Infiltrates in Gliomas

Xiaoping Xu et al.

Summary: Accumulating evidence has shown that dysregulated lncRNA expression plays a role in cancer progression. This study focused on evaluating the significance of MEG3 in glioma prognosis and its immune-related roles. The results indicated that MEG3 expression was correlated with patient survival and prognosis, as well as with tumor-infiltrating immune cells in gliomas.

FRONTIERS IN GENETICS (2021)

Article Genetics & Heredity

The Impact of Single Nucleotide Polymorphism in the Long Non-coding MEG3 Gene on MicroRNA-182 and MicroRNA-29 Expression Levels in the Development of Breast Cancer in Egyptian Women

Olfat Shaker et al.

Summary: The study found an association between MEG3 rs7158663 G/A genotype and breast cancer risk, with the A allele having a significantly higher frequency in patients. MEG3, miR-182, and miRNA-29 are key genes in the development of breast cancer and may serve as novel potential non-invasive diagnostic biomarkers for the disease.

FRONTIERS IN GENETICS (2021)

Article Oncology

LncRNA MEG3 promotes endoplasmic reticulum stress and suppresses proliferation and invasion of colorectal carcinoma cells through the MEG3/miR-103a-3p/PDHB ceRNA pathway

Guoqin Wang et al.

Summary: MEG3 functions as a suppressor in colorectal carcinoma by inhibiting malignancy and proliferation of cancer cells, inducing ER stress, and suppressing invasion; miR-103a-3p is a target of MEG3 and is also involved in targeting PDHB; the ceRNA pathway involving MEG3 may represent a novel mechanism in regulating colorectal carcinoma.

NEOPLASMA (2021)

Article Biochemistry & Molecular Biology

Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer

Honglin Yan et al.

Summary: The study revealed that cisplatin induces pyroptosis in triple-negative breast cancer cells through activation of the MEG3/NLRP3/caspase-1/GSDMD pathway, leading to its anti-tumor effects. This finding may contribute to the development of new therapeutic strategies for TNBC.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Cell Biology

MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN

Guang Shan et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Article Medicine, Research & Experimental

lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143

Yanlan Yu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Biochemistry & Molecular Biology

MEG3 is restored by schisandrin A and represses tumor growth in choriocarcinoma cells

Li Ji et al.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)

Article Cell Biology

LncRNA MEG3 inhibits the inflammatory response of ankylosing spondylitis by targeting miR-146a

Yehong Li et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)

Article Biotechnology & Applied Microbiology

Tumor-Suppressive Function of lncRNA-MEG3 in Glioma Cells by Regulating miR-6088/SMARCB1 Axis

Xin Gong et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Medicine, Research & Experimental

Promoter hypermethylation influences the suppressive role of long non-coding RNA MEG3 in the development of multiple myeloma

Wenjun Yu et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)

Article Oncology

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer

Marianna Buttarelli et al.

CANCERS (2020)

Article Biotechnology & Applied Microbiology

Tissue-based long non-coding RNAs PVT1, TUG1 and MEG3 signature predicts Cisplatin resistance in ovarian Cancer

Nashwa El-Khazragy et al.

GENOMICS (2020)

Article Medical Laboratory Technology

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells

Hongchang Li et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Article Cell & Tissue Engineering

Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically

Xiaoxue Jiang et al.

STEM CELL RESEARCH & THERAPY (2020)

Article Biochemistry & Molecular Biology

MEG3 targets miR-184 and Wnt/β-catenin and modulates properties of osteosarcoma

Liang Li et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2020)

Article Biochemistry & Molecular Biology

Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition

Mujie Ye et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Cell Biology

LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma

Jinglin Li et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Dentistry, Oral Surgery & Medicine

Association of long non-coding RNA MEG3 polymorphisms with oral squamous cell carcinoma risk

Yunwen Hou et al.

ORAL DISEASES (2019)

Article Biochemistry & Molecular Biology

Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2

Zhuoyang Fan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Cell Biology

LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis

Xiaowen Zhang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR

Lei Wang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Medicine, Research & Experimental

MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion

Chao Huang et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Article Cell Biology

LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway

Guoqing Li et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Medicine, Research & Experimental

High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway

Xin Li et al.

LIFE SCIENCES (2019)

Article Gastroenterology & Hepatology

LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer

Wei Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Biochemistry & Molecular Biology

MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway

Mingzhi Zhu et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)

Article Medicine, Research & Experimental

Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis

Yongjuan Zhao et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Cell Biology

LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis

Meng Wu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53

Yan Zhang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs

Ming Jiang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Biology

lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11

Zhi Liu et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)

Article Medicine, Research & Experimental

LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer

Jie Dan et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Medicine, Research & Experimental

Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21

Ziye Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Medicine, Research & Experimental

LncRNA MEG3 enhances 131I sensitivity in thyroid carcinoma via sponging miR-182

Yang Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Biochemistry & Molecular Biology

MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3

Hai-Bin Cui et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway

Peng Li et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Biotechnology & Applied Microbiology

lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p

Jianwen Long et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Article Biochemistry & Molecular Biology

Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation

Jianhao Xu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Medicine, Research & Experimental

Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis

Hongjian Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Cell Biology

Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis

Xiangrong Cui et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma

Wing-Po Chak et al.

MOLECULAR CARCINOGENESIS (2017)

Article Medicine, Research & Experimental

Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma

Yali Gao et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Article Biochemistry & Molecular Biology

The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis

Jin Xu et al.

CELL AND BIOSCIENCE (2017)

Article Multidisciplinary Sciences

Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer

Jun Zhang et al.

SCIENTIFIC REPORTS (2017)

Article Cell Biology

MEG3 Suppresses Human Pancreatic Neuroendocrine Tumor Cells Growth and Metastasis by Down-Regulation of Mir-183

Yuan-Yuan Zhang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Obstetrics & Gynecology

Primary choriocarcinoma in postmenopausal women: Two case reports and review of the Texas Cancer Registry

Leslie F. Rafanan et al.

GYNECOLOGIC ONCOLOGY REPORTS (2017)

Article Medicine, Research & Experimental

LncRNA MEG3 has anti-activity effects of cervical cancer

Wang Xiaoguang et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Biochemistry & Molecular Biology

LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway

Kai-Xuan Sun et al.

APOPTOSIS (2017)

Review Ophthalmology

Retinoblastoma: Update on Current Management

Nathalie Cassoux et al.

ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY (2017)

Article Biochemistry & Molecular Biology

LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21

Xiangyu Zhou et al.

BIOMOLECULES & THERAPEUTICS (2017)

Article Biochemistry & Molecular Biology

Inhibition of miR-664a interferes with the migration of osteosarcoma cells via modulation of MEG3

Yunus Sahin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Medicine, Research & Experimental

LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer

Wei Zhang et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Medicine, Research & Experimental

lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity

Lei Gu et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Biochemistry & Molecular Biology

The Aberrant Expression of MEG3 Regulated by UHRF1 Predicts the Prognosis of Hepatocellular Carcinoma

Han Zhuo et al.

MOLECULAR CARCINOGENESIS (2016)

Article Biochemistry & Molecular Biology

Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3

Duanmin Hu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity

Lin Sun et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Medicine, Research & Experimental

LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling

Qingyun Guo et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Biochemistry & Molecular Biology

Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression

Lishan Sun et al.

DNA AND CELL BIOLOGY (2016)

Article Medicine, General & Internal

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

R. L. Ferris et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Cell Biology

Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer

Gang Luo et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)

Article Gastroenterology & Hepatology

MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression

Xiaoying Zhou et al.

DIGESTIVE DISEASES AND SCIENCES (2015)

Article Oncology

Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression

Weizhao Peng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

Long non-coding RNA MEG3 induces renal cell carcinoma cells apoptosis by activating the mitochondrial pathway

Miao Wang et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2015)

Article Endocrinology & Metabolism

Epigenetic Regulation of the lncRNA MEG3 and Its Target c-MET in Pancreatic Neuroendocrine Tumors

Sita D. Modali et al.

MOLECULAR ENDOCRINOLOGY (2015)

Review Gastroenterology & Hepatology

Review article: the epidemiology and prevention of gastric cancer

K. M. Fock

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Oncology

Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma

Ling-Fei Jia et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

News Item Oncology

Osteosarcoma survivors' risk of second cancer

Sanjeet Bagcchi

LANCET ONCOLOGY (2014)

Article Biochemistry & Molecular Biology

Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer

Liang Ying et al.

MOLECULAR BIOSYSTEMS (2013)

Article Multidisciplinary Sciences

Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma

Sumadi Lukman Anwar et al.

PLOS ONE (2012)

Review Oncology

Gastric cancer

Vincenzo Catalano et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)

Review Multidisciplinary Sciences

Melanoma biology and new targeted therapy

Vanessa Gray-Schopfer et al.

NATURE (2007)